Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Envoy Medical, Inc. entered into Extension Support Agreements with several unaffiliated third parties (Holders) valued at Sponsor agreed to transfer up to 80,000 Founder Shares per Holder for every 100,000 Public Shares re (effective 2023-02-23).
- Action
- entry
- Counterparty
- several unaffiliated third parties (Holders)
- Value
- Sponsor agreed to transfer up to 80,000 Founder Shares per Holder for every 100,000 Public Shares re
- Effective
- 2023-02-23
Exact text from the filing
On February 23, 2023, in connection with the special meeting of stockholders (the “ Special Meeting ”) of Anzu Special Acquisition Corp I, a Delaware corporation (the “ Company ”), to extend the date by which the Company has to consummate a business combination from March 4, 2023 to September 30, 2023 or such earlier date as determined by the Company’s board of directors (the “ Extension Amendment Proposal ”), the Company and Anzu SPAC GP I LLC (the “ Sponsor ”) entered into extension support agreements (the “ Extension Support Agreements ”) with several unaffiliated third parties (each, a “ Holder ”), pursuant to which each Holder agreed to (i) notify the Sponsor at least three business days prior to the Special Meeting regarding the number of shares of the Company’s Class A common stock (“ Public Shares ”) that such Holder intends to redeem and the number of Public Shares that such Holder intends to retain in connection with the Special Meeting and (ii) vote (and to cause its control
View on SEC.gov